Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease - Wikidata - wikimedia - TriplyDB

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

http://www.wikidata.org/entity/Q58752270

about

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

http://www.wikidata.org/entity/Q58752270

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Relationship between low level ...... ts with chronic kidney disease

@en

Relationship between low level ...... ts with chronic kidney disease

@nl

type

label

Relationship between low level ...... ts with chronic kidney disease

@en

Relationship between low level ...... ts with chronic kidney disease

@nl

prefLabel

Relationship between low level ...... ts with chronic kidney disease

@en

Relationship between low level ...... ts with chronic kidney disease

@nl

P1433

Q58752270-5A1FC063-2B55-4899-BF45-660ECA9FFDCE

P1476

Q58752270-7FB16733-84DC-4872-8EF9-9460913FE7FC

P2093

Q58752270-0056F2D8-1C13-4C1A-B053-1DE7BB6B5E7D

Q58752270-3B633281-ABCF-442D-9488-40BA84289556

Q58752270-6A7FE5C3-AC31-4B16-8B9B-BDC3663B3A7E

Q58752270-6BA2F610-4C09-4957-9E9A-B00C21C50515

Q58752270-84BBD8E4-CED6-46EF-A584-38BB7F903A9F

Q58752270-894DF3EA-032D-465A-87B5-D6F2EECE2529

Q58752270-8ADC8559-53EA-4F52-BB6E-7CAE17CEFC03

Q58752270-A7D5342F-934A-4847-A351-0F356B471438

Q58752270-BDFE870C-96E2-43F6-8D2E-456DD969ED70

Q58752270-EF373EF8-A347-4915-A3D9-1E096D239FA5

P2860

Q58752270-04209477-E398-4866-A540-41A846F63A09

Q58752270-08681AF7-2B12-4761-9CB0-34F3115B0762

Q58752270-09207C37-3A21-4207-B3ED-33FC505CC230

Q58752270-0B1DA10B-7E9E-45B1-899E-D217DA1931D1

Q58752270-0DC407E5-0D68-4313-9139-3E6E38ADE594

Q58752270-0FCADB39-B079-4D0B-8014-48E375775003

Q58752270-11FDE509-5221-4DB8-92D8-9228349B9930

Q58752270-12116AEB-B069-415E-8E4B-4413D557DB69

Q58752270-1D868D0A-5B65-4996-9C7C-5B3F2E196385

Q58752270-26AACC9A-9B4F-41CD-9E8B-CB9F4B19B4D2

P304

Q58752270-C868A32F-0E1F-4CD7-A24E-8409F401B357

P31

Q58752270-44C7D168-6E9A-4930-8731-B391278CE9AF

P356

Q58752270-AE6523A4-2132-46BD-BB05-485D3E0512E5

P407

Q58752270-78C78BA0-01A5-4050-BF66-E3AC703B8DA6

P433

Q58752270-E8148E81-7506-4FD0-A6A3-69C51C096FA9

P478

Q58752270-95FA89B0-459C-4CF5-9DDA-3142B48A1757

P50

Q58752270-01E5D43A-4F9A-4C32-866F-17E11EC4B3D5

Q58752270-6FAB495A-12E5-4CF9-B318-5E9C3D33B20F

Q58752270-EEF38684-4D53-4A97-9DDD-F095B88E8FAD

P577

Q58752270-9E601FE1-235E-4C9E-AC30-72022A733095

P698

Q58752270-E7A07C5A-BE53-40EA-A1F2-97346DEC186F

P932

Q58752270-49DB0692-A4F5-4F95-A44F-6AB1E76A6002

P356

JOURNAL.PONE.0203716

P1433

P1476

Relationship between low level ...... ts with chronic kidney disease

@en

P2093

Elisa Maietti

http://www.w3.org/2001/XMLSchema#string

Elisabetta Melloni

http://www.w3.org/2001/XMLSchema#string

Elvira Fernández

http://www.w3.org/2001/XMLSchema#string

Erika Rimondi

http://www.w3.org/2001/XMLSchema#string

Giorgio Zauli

http://www.w3.org/2001/XMLSchema#string

Paola Secchiero

http://www.w3.org/2001/XMLSchema#string

Rebecca Voltan

http://www.w3.org/2001/XMLSchema#string

Stefania Gallo

http://www.w3.org/2001/XMLSchema#string

Stefano Volpato

http://www.w3.org/2001/XMLSchema#string

Àngels Betriu

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Vascular Smooth Muscle Cells in Atherosclerosis.

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes

Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome.

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.

Association of soluble Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) with central adiposity and low-density lipoprotein cholesterol.

Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V

P304

e0203716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0203716

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jose M Valdivielso

Veronica Tisato

Maria Vittoria Arcidiacono

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30204795

http://www.w3.org/2001/XMLSchema#string

P932

6133360

http://www.w3.org/2001/XMLSchema#string